The price of main products has reached a new high in recent years and the first quarter net profit of Hebang Bio is expected to increase by 303%-339% _ Oriental Fortune Net

　　Hebang BioThe first quarter of 2022 will be disclosed on the evening of April 11performancepre-incrementannouncementthe company expects to be attributable to listed companies in the first quartershareholderofnet profitIt is 1,010,000-1,100,000 yuan, an increase of 759,200,000-849,202,500 yuan compared with the same period of the previous year, a year-on-year increase of 302.72%-338.60%; the net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses is 1,010,000-1,100,000,000 yuan, and Compared with the same period last year, it will increase by 760.7255-850.7255 million yuan, an increase of 305.18%-341.28% year-on-year.

The company disclosed that there are three main factors behind the substantial growth in the first quarter’s performance. First, the sales price of the company’s products has increased year-on-year. The price of the company’s main product ammonium chloride (mainly used for the production of compound fertilizer) has increased significantly year-on-year, hitting a new high in recent years. The second phase of the company’s employee stock ownership plan was completed through non-transactional transfer in January this year. According to “Accounting Standards for Business Enterprises No. 11 – Share-based Payments”, it is expected that this issue will be confirmed in the first quarter. The cost is about 104 million yuan, which is included in the profit and loss of the reporting period; thirdly, under the guidance of the development strategy of “focus, professionalism, excellence, and strength”, the company has continuously adopted measures such as independent technological innovation, process innovation, and introduction of advanced technology. and means to achieve the continuous improvement of the cost control level and create the technical conditions for the company to obtain a good profit space. (Tian Limin)

(Article source: ShanghaisecuritiesNewspaper Chinasecuritiesnetwork)

Article source: Shanghai Securities News China Securities Network

Responsible editor: 91

Original title: The price of main products has reached a new high in recent years and the first quarter net profit of Hebang Bio is expected to increase by 303%-339%